These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 8153675

  • 1. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B.
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
    Stebler C, Tichelli A, Dazzi H, Gratwohl A, Nissen C, Speck B.
    Exp Hematol; 1990 Dec 13; 18(11):1204-8. PubMed ID: 2226680
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. r-HuEPO treatment of anemia associated with multiple myeloma and ESRD.
    Van der Niepen P, Sennesael J, Verbeelen D.
    Clin Nephrol; 1993 Feb 13; 39(2):113. PubMed ID: 8448915
    [No Abstract] [Full Text] [Related]

  • 9. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH, Brooks BJ, Case DC, Fishkin E, Jacobson R, Keller AM, Kugler J, Moore J, Silver RT, Storniolo AM, Abels RI, Gordon DS, Nelson R, Larholt K, Bryant E, Rudnick S.
    Cancer J Sci Am; 1995 Feb 13; 1(4):252-60. PubMed ID: 9166485
    [Abstract] [Full Text] [Related]

  • 10. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan 13; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

  • 11. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
    Urabe A, Mizoguchi H, Takaku F, Miyazaki T, Yachi A, Niitsu Y, Miura Y, Mutoh Y, Fujioka S, Nomura T.
    Rinsho Ketsueki; 1993 Aug 13; 34(8):919-27. PubMed ID: 8411646
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS.
    Ann Intern Med; 1992 Nov 01; 117(9):739-48. PubMed ID: 1416576
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL, Nolan TA, Piraino B.
    Clin Nephrol; 1992 Mar 01; 37(3):145-7. PubMed ID: 1563119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G.
    J Pak Med Assoc; 1998 May 01; 48(5):127-31. PubMed ID: 9813972
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin treatment of anemia associated with multiple myeloma.
    Ludwig H, Fritz E, Kotzmann H, Höcker P, Gisslinger H, Barnas U.
    N Engl J Med; 1990 Jun 14; 322(24):1693-9. PubMed ID: 2342535
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN, Chaidos A, Gouva M, Christou L, Panteli K, Kapsali E, Bourantas KL.
    J Exp Clin Cancer Res; 2004 Mar 14; 23(1):47-52. PubMed ID: 15149150
    [Abstract] [Full Text] [Related]

  • 20. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin].
    Nakata H, Matsuzaki M, Shimamoto Y, Yamaguchi M.
    Rinsho Ketsueki; 1990 Oct 14; 31(10):1752-3. PubMed ID: 2255069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.